Found 6 results. Export: Tagged | XML
Filters: keyword is Membrane Proteins  [Clear All Filters]
2005
Huntjens, D.R., Danhof, M., Della Pasqua, O.E. , Pharmacokinetic-pharmacodynamic correlations and biomarkers in the development of COX-2 inhibitors, Rheumatology (Oxford), vol. 44, no. 7, pp. 846-59. DOI
1999
Snoeck, E., Jacqmin, P., Van Peer, A., Danhof, M. , A combined specific target site binding and pharmacokinetic model to explore the non-linear disposition of draflazine, J Pharmacokinet Biopharm, vol. 27, no. 3, pp. 257-81.
Cleton, A., de Greef, H.J., Edelbroek, P.M., Voskuyl, R.A., Danhof, M. , Stereoselective central nervous system effects of the R- and S-isomers of the GABA uptake blocker N-(4, 4-di-(3-methylthien-2-yl)but-3-enyl) nipecotic acid in the rat, Br J Pharmacol, vol. 128, no. 8, pp. 1651-8. DOI
1998
Snoeck, E., Ver Donck, K., Jacqmin, P., Van Belle, H., Dupont, A.G., Van Peer, A., Danhof, M. , Physiological red blood cell kinetic model to explain the apparent discrepancy between adenosine breakdown inhibition and nucleoside transporter occupancy of draflazine, J Pharmacol Exp Ther, vol. 286, no. 1, pp. 142-9.
1997
Snoeck, E., Piotrovskij, V., Jacqmin, P., Lins, R.L., Van Peer, A., Danhof, M., Woestenborghs, R., Van Gool, R., Dupont, A.G., Heykants, J. , Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations, Eur J Clin Pharmacol, vol. 53, no. 1, pp. 57-63.
1996
Snoeck, E., Jacqmin, P., Van Peer, A., Danhof, M., Ver Donck, K., Van Belle, H., Woestenborghs, R., Crabbe, R., Van Gool, R., Dupont, A., Heykants, J. , The implications of non-linear red blood cell partitioning for the pharmacokinetics and pharmacodynamics of the nucleoside transport inhibitor draflazine, Br J Clin Pharmacol, vol. 42, no. 5, pp. 605-13.